The analysis of the Oncomine database revealed fold-changes in gene expression levels that MTHFD2 expression was significantly increased in ovarian mucinous adenocarcinoma, ovarian serous adenocarcinoma, ovarian endometrioid adenocarcinoma compared with normal samples. The gene discussed is MTHFD2; the disease is ovarian serous adenocarcinoma.